Search research articles
Contact Us
Filters
Showing results (161-170 of 195) with videos related to
Page
of 20
Sort By:
Translational Cancer Research
|
September 12, 2022
Prognostic factors in Japanese men with high-Gleason metastatic castration-resistant prostate cancer
Mitsuhisa Nishimoto, Kazutoshi Fujita, Yutaka Yamamoto, et al.
Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society
|
August 12, 2025
Clinical and Neuroimaging Features of Tactile Hallucinations in Patients With Dementia With Lewy Bodies: A Cross-Sectional Study
Kyosuke Kakeda, Hideki Kanemoto, Kenji Yoshiyama, et al.
The Prostate
|
January 31, 2025
Immunohistochemical Analysis of Androgen Receptor Expression Predicts the Prognosis of Metastatic Castration-Sensitive Prostate Cancer Patients Receiving Abiraterone Acetate
Mitsuhisa Nishimoto, Marco A De Velasco, Yutaka Yamamoto, et al.
Fluids and Barriers of the CNS
|
December 19, 2024
Association between choroid plexus volume and cognitive function in community-dwelling older adults without dementia: a population-based cross-sectional analysis
Yosuke Hidaka, Mamoru Hashimoto, Takashi Suehiro, et al.
Cancer Diagnosis & Prognosis
|
July 4, 2024
Gleason Pattern 5 May Be a Prognostic Factor in Radium-223 Treatment
Mitsuhisa Nishimoto, Kazutoshi Fujita, Aritoshi Ri, et al.
The Journal of Urology
|
October 3, 2025
Diagnostic Accuracy of the Oncuria-Detect Multiplex Immunoassay in Detecting Upper Tract Urothelial Carcinoma
Kazutoshi Fujita, Makito Miyake, Mamoru Hashimoto, et al.
In Vivo (Athens, Greece)
|
April 28, 2025
Cancer-induced Pain Is Associated With Poor Overall Survival of Urothelial Carcinoma Patients Treated With Enfortumab Vedotin
Mamoru Hashimoto, Ken Fukiage, Kosei Taniguchi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
August 14, 2025
Comparison of Oncological Outcomes of Conventional Androgen Deprivation Therapy (ADT) and ADT Plus Androgen Receptor Signaling Inhibitor in Older Patients With Metastatic Castration-Sensitive Prostate Cancer
Yutaka Yamamoto, Saizo Fujimoto, Mamoru Hashimoto, et al.
Translational Andrology and Urology
|
September 15, 2025
Upper urinary tract urothelial carcinoma patients show better overall response rate than bladder cancer patients during enfortumab vedotin treatment following pembrolizumab
Mamoru Hashimoto, Ken Fukiage, Kosei Taniguchi, et al.
International Journal of Clinical Oncology
|
October 1, 2024
Real-world outcomes in patients with metastatic castration-resistant prostate cancer beyond progression after upfront androgen receptor signaling inhibitor
Yutaka Yamamoto, Saizo Fujimoto, Mamoru Hashimoto, et al.
Page
of 20
Search research articles
Search
Showing results (161-170 of 195) with videos related to
Sort By:
Page
of 20
Translational Cancer Research
|
September 12, 2022
Prognostic factors in Japanese men with high-Gleason metastatic castration-resistant prostate cancer
Mitsuhisa Nishimoto, Kazutoshi Fujita, Yutaka Yamamoto, et al.
Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society
|
August 12, 2025
Clinical and Neuroimaging Features of Tactile Hallucinations in Patients With Dementia With Lewy Bodies: A Cross-Sectional Study
Kyosuke Kakeda, Hideki Kanemoto, Kenji Yoshiyama, et al.
The Prostate
|
January 31, 2025
Immunohistochemical Analysis of Androgen Receptor Expression Predicts the Prognosis of Metastatic Castration-Sensitive Prostate Cancer Patients Receiving Abiraterone Acetate
Mitsuhisa Nishimoto, Marco A De Velasco, Yutaka Yamamoto, et al.
Fluids and Barriers of the CNS
|
December 19, 2024
Association between choroid plexus volume and cognitive function in community-dwelling older adults without dementia: a population-based cross-sectional analysis
Yosuke Hidaka, Mamoru Hashimoto, Takashi Suehiro, et al.
Cancer Diagnosis & Prognosis
|
July 4, 2024
Gleason Pattern 5 May Be a Prognostic Factor in Radium-223 Treatment
Mitsuhisa Nishimoto, Kazutoshi Fujita, Aritoshi Ri, et al.
The Journal of Urology
|
October 3, 2025
Diagnostic Accuracy of the Oncuria-Detect Multiplex Immunoassay in Detecting Upper Tract Urothelial Carcinoma
Kazutoshi Fujita, Makito Miyake, Mamoru Hashimoto, et al.
In Vivo (Athens, Greece)
|
April 28, 2025
Cancer-induced Pain Is Associated With Poor Overall Survival of Urothelial Carcinoma Patients Treated With Enfortumab Vedotin
Mamoru Hashimoto, Ken Fukiage, Kosei Taniguchi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
August 14, 2025
Comparison of Oncological Outcomes of Conventional Androgen Deprivation Therapy (ADT) and ADT Plus Androgen Receptor Signaling Inhibitor in Older Patients With Metastatic Castration-Sensitive Prostate Cancer
Yutaka Yamamoto, Saizo Fujimoto, Mamoru Hashimoto, et al.
Translational Andrology and Urology
|
September 15, 2025
Upper urinary tract urothelial carcinoma patients show better overall response rate than bladder cancer patients during enfortumab vedotin treatment following pembrolizumab
Mamoru Hashimoto, Ken Fukiage, Kosei Taniguchi, et al.
International Journal of Clinical Oncology
|
October 1, 2024
Real-world outcomes in patients with metastatic castration-resistant prostate cancer beyond progression after upfront androgen receptor signaling inhibitor
Yutaka Yamamoto, Saizo Fujimoto, Mamoru Hashimoto, et al.
Page
of 20